The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...